Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Hernia
Interventions: acellular porcine dermal collagen mesh; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 3
States / cities: Lexington, Kentucky • Albany, New York • Greenville, South Carolina

Conditions: Breast Cancer
Interventions: FFDM Plus DBT, FFDM Alone; Device
Lead sponsor: Fujifilm Medical Systems USA, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 298 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Scottsdale, Arizona • Iowa City, Iowa • Rochester, New York + 2 more

Conditions: Spinocerebellar Ataxia
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder, Working Memory
Interventions: Transcranial Magnetic Stimulation (TMS), High controllability TMS target; Device · Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 28 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Retinopathy
Interventions: Topcon Camera, Optos Camera, Clarus Camera; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Musculoskeletal Injuries
Interventions: PREPARE Initial Clinical Assessment - Pilot (two iterations), PREPARE Initial Clinical Assessment - Pre-Injury (one iteration), PREPARE Initial Clinical Assessment - Post-Injury (up to three iterations), PREPARE Optimized Clinical Assessment; Other
Lead sponsor: Womack Army Medical Center; Federal
Eligibility: 18 Years to 44 Years
Enrollment: 2,690 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Bethesda, Maryland • Fort Liberty, North Carolina

Conditions: Breast Health
Interventions: Full Field Digital Mammography, Digital Breast Tomosynthesis; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 40 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke
Interventions: Behavioral Dietary intervention ( MIND Diet), Behavioral Usual Care Diet Intervention; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 55 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Parkinson Disease
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 55 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Alcohol Drinking, Alcohol Intoxication, Alcohol Use, Unspecified
Interventions: WayToServe Plus In-service Component, WayToServe Training Only; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Golden, Colorado

Conditions: Iron Deficiency
Interventions: Quadruple sequential Helicobacter pylori eradication + iron sulfate, Quadruple sequential Helicobacter pylori eradication therapy, Ferrous sulfate, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 36 Months to 120 Months
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Headache
Interventions: Superficial Dry Needling, Non-thrust Mobilizations only; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Hemophilia a
Interventions: Case scenarios - questionnaire, Case scenarios - Focus groups, Use scenarios - Usability test, Use scenarios - interview; Other
Lead sponsor: Enzyre B.V.; Industry
Eligibility: 12 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Gulf War Syndrome, Gulf War Illness, Headache, Muscle Pain, Joint Pain
Interventions: Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation; Device
Lead sponsor: Veterans Medical Research Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Palo Alto, California • San Diego, California • Decatur, Georgia

Conditions: Occipital Transcranial Magnetic Stimulation
Interventions: Sham TMS condition, OffLine TMS Condition, Online TMS condition; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Epilepsy
Interventions: transcranial magnetic stimulation (TMS); Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obsessive Compulsive Disorder
Interventions: Active DTMS Treatment, Sham Treatment; Device
Lead sponsor: Brainsway; Industry
Eligibility: 22 Years to 68 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 10
States / cities: Los Angeles, California • San Diego, California • Gainesville, Florida + 5 more

Conditions: Neoplasms, Malignant, Breast Neoplasm, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasm, Head and Neck Neoplasms
Interventions: Carlo Erba Ink Injection, EPR Oximetry Measurement; Device · Other
Lead sponsor: Philip Schaner; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Dementia With Lewy Bodies, Parkinson Disease, REM Sleep Behavior Disorder
Interventions: Skin biopsy, Speech testing, Ultra high field 7T MRI; Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Arthritis, Rheumatoid
Interventions: Tc99m-tilmanocept, SPECT Imaging (60 Minutes post-injection), SPECT Imaging (180 Minutes post-injection), Whole body planar SPECT imaging (15 Minutes post-injection), Whole body planar SPECT imaging (60 Minutes post-injection), Whole body planar SPECT imaging (180 Minutes post-injection), Whole body planar SPECT imaging (18-20 Hours post-injection), Blood Collection for PK Testing (15 Mins Before Injection), Blood Collection for PK Testing (after injection), Blood Collection for PK Testing (15 minutes post injection), Blood Collection for PK Testing (60 minutes post injection), Blood Collection for PK Testing (180 minutes post injection), Blood Collection for PK Testing (18-20 hours post injection), Planar Image with both Hands in Field of View; Drug · Procedure
Lead sponsor: Navidea Biopharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Kettering, Ohio

Conditions: Cyclic Vomiting Syndrome
Interventions: Active percutaneous electrical nerve field stimulation, Sham percutaneous electrical nerve field stimulation; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Depression, Depressive Disorder, Depressive Disorder, Treatment-resistant, Depressive Disorder, Major
Interventions: LFMS; Device
Lead sponsor: Tal Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 12
States / cities: Garden Grove, California • Lemon Grove, California • Oakland, California + 9 more

Conditions: Actinic Keratosis
Interventions: Ingenol Mebutate, Vehicle; Drug · Other
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 729 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Carmel, Indiana

Conditions: PTSD
Interventions: fMRI - GE Medical System; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Feasibility of Permacol Use in Infected Fields

A Multi-Reader Multi-Case Pivotal Trial

Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia

Network Control TMS fMRI

Comparing 3 Imaging Systems

Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement

Image Quality Assessment for Screening and Diagnostic Mammography

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

Apathy in Parkinson Disease TMS Study

WayToServePlus: Improving Responsible Alcohol Service Ph II

Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children

Superficial Dry Needling for Cervicogenic Headache

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring

Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms

TMS of Visual Working Memory

Transcranial Magnetic Stimulation to Treat Epilepsy

An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

EPR Tumor Oximetry With CE India Ink

5-HT RBD REM Sleep Behavior Disorder

Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA

A Study of Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Neurofeedback With Real-Time fMRI for Treatment of PTSD